BiochemistrybioRxivPreprint
Repurposing covalent EGFR/HER2 inhibitors for on-target degradation of human Tribbles 2 (TRIB2) pseudokinase
Daniel M Foulkes, Dominic P Byrne, Fiona P Bailey…·Patrick A Eyers
The paper identifies EGFR/HER2 inhibitors that destabilize and degrade TRIB2 pseudokinase in cancer cells, suggesting potential for TRIB2-targeted therapies.
DOI 10.1101/305243